These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22183556)

  • 1. Molecular dynamics applied in drug discovery: the case of HIV-1 protease.
    Shang Y; Simmerling C
    Methods Mol Biol; 2012; 819():527-49. PubMed ID: 22183556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placevent: an algorithm for prediction of explicit solvent atom distribution-application to HIV-1 protease and F-ATP synthase.
    Sindhikara DJ; Yoshida N; Hirata F
    J Comput Chem; 2012 Jul; 33(18):1536-43. PubMed ID: 22522665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolution of discordant HIV-1 protease resistance rankings using molecular dynamics simulations.
    Wright DW; Coveney PV
    J Chem Inf Model; 2011 Oct; 51(10):2636-49. PubMed ID: 21902276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crucial roles of the subnanosecond local dynamics of the flap tips in the global conformational changes of HIV-1 protease.
    Li D; Ji B; Hwang K; Huang Y
    J Phys Chem B; 2010 Mar; 114(8):3060-9. PubMed ID: 20143801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A molecular dynamics study comparing a wild-type with a multiple drug resistant HIV protease: differences in flap and aspartate 25 cavity dimensions.
    Seibold SA; Cukier RI
    Proteins; 2007 Nov; 69(3):551-65. PubMed ID: 17623840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solvation shell structure of cyclooctylpyranone in water solvent and its comparative structure, dynamics and dipole moment in HIV protease.
    Arul Murugan N; Chandra Jha P; Agren H
    Phys Chem Chem Phys; 2009 Aug; 11(30):6482-9. PubMed ID: 19809680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Explicit solvent dynamics and energetics of HIV-1 protease flap opening and closing.
    Sadiq SK; De Fabritiis G
    Proteins; 2010 Nov; 78(14):2873-85. PubMed ID: 20715057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restrained molecular dynamics simulations of HIV-1 protease: the first step in validating a new target for drug design.
    Perryman AL; Lin JH; McCammon JA
    Biopolymers; 2006 Jun; 82(3):272-84. PubMed ID: 16508951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-water interactions in MD simulations: POPS/POPSCOMP solvent accessibility analysis, solvation forces and hydration sites.
    Fornili A; Autore F; Chakroun N; Martinez P; Fraternali F
    Methods Mol Biol; 2012; 819():375-92. PubMed ID: 22183548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into a mutation-assisted lateral drug escape mechanism from the HIV-1 protease active site.
    Sadiq SK; Wan S; Coveney PV
    Biochemistry; 2007 Dec; 46(51):14865-77. PubMed ID: 18052195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic flaps in HIV-1 protease adopt unique ordering at different stages in the catalytic cycle.
    Karthik S; Senapati S
    Proteins; 2011 Jun; 79(6):1830-40. PubMed ID: 21465560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure, dynamics and solvation of HIV-1 protease/saquinavir complex in aqueous solution and their contributions to drug resistance: molecular dynamic simulations.
    Wittayanarakul K; Aruksakunwong O; Sompornpisut P; Sanghiran-Lee V; Parasuk V; Pinitglang S; Hannongbua S
    J Chem Inf Model; 2005; 45(2):300-8. PubMed ID: 15807491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of conformational fluctuations in the enzymatic reaction of HIV-1 protease.
    Piana S; Carloni P; Parrinello M
    J Mol Biol; 2002 May; 319(2):567-83. PubMed ID: 12051929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accurate ensemble molecular dynamics binding free energy ranking of multidrug-resistant HIV-1 proteases.
    Sadiq SK; Wright DW; Kenway OA; Coveney PV
    J Chem Inf Model; 2010 May; 50(5):890-905. PubMed ID: 20384328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand conformational and solvation/desolvation free energy in protein-ligand complex formation.
    Kolár M; Fanfrlík J; Hobza P
    J Phys Chem B; 2011 Apr; 115(16):4718-24. PubMed ID: 21466174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solvation influences flap collapse in HIV-1 protease.
    Meagher KL; Carlson HA
    Proteins; 2005 Jan; 58(1):119-25. PubMed ID: 15521062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics simulations of ligand-induced flap closing in HIV-1 protease approach X-ray resolution: establishing the role of bound water in the flap closing mechanism.
    Singh G; Senapati S
    Biochemistry; 2008 Oct; 47(40):10657-64. PubMed ID: 18785756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An insight into the opening path to semi-open conformation of HIV-1 protease by molecular dynamics simulation.
    Lu T; Chen Y; Li XY
    AIDS; 2010 May; 24(8):1121-5. PubMed ID: 20299960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamics simulations of peptides and proteins with a continuum electrostatic model based on screened Coulomb potentials.
    Hassan SA; Mehler EL; Zhang D; Weinstein H
    Proteins; 2003 Apr; 51(1):109-25. PubMed ID: 12596268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free energy calculations on dimer stability of the HIV protease using molecular dynamics and a continuum solvent model.
    Wang W; Kollman PA
    J Mol Biol; 2000 Nov; 303(4):567-82. PubMed ID: 11054292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.